Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 Oct;77(10):662–672. doi: 10.1136/bjo.77.10.662

Clinical and genetic patterns of neurofibromatosis 1 and 2.

N K Ragge 1
PMCID: PMC504612  PMID: 8218038

Abstract

Full text

PDF
662

Images in this article

663Image
on p.663
663Image
on p.663
664Image
on p.664
664Image
on p.664
664Image
on p.664
664Image
on p.664
669Image
on p.669
669Image
on p.669
669Image
on p.669
669Image
on p.669
669Image
on p.669

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allanson J. E., Upadhyaya M., Watson G. H., Partington M., MacKenzie A., Lahey D., MacLeod H., Sarfarazi M., Broadhead W., Harper P. S. Watson syndrome: is it a subtype of type 1 neurofibromatosis? J Med Genet. 1991 Nov;28(11):752–756. doi: 10.1136/jmg.28.11.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersen L. B., Fountain J. W., Gutmann D. H., Tarlé S. A., Glover T. W., Dracopoli N. C., Housman D. E., Collins F. S. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet. 1993 Feb;3(2):118–121. doi: 10.1038/ng0293-118. [DOI] [PubMed] [Google Scholar]
  3. Andersen L. B., Wallace M. R., Marchuk D. A., Tavakkol R., Mitchell A., Saulino A. M., Collins F. S. A highly polymorphic cDNA probe in the NF1 gene. Nucleic Acids Res. 1991 Jul 11;19(13):3754–3754. doi: 10.1093/nar/19.13.3754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bader J. L. Neurofibromatosis and cancer. Ann N Y Acad Sci. 1986;486:57–65. doi: 10.1111/j.1749-6632.1986.tb48062.x. [DOI] [PubMed] [Google Scholar]
  5. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990 Nov 16;63(4):851–859. doi: 10.1016/0092-8674(90)90151-4. [DOI] [PubMed] [Google Scholar]
  6. Boltshauser E., Stocker H., Mächler M. Neurofibromatosis type 1 in a child of a parent with segmental neurofibromatosis (NF-5). Neurofibromatosis. 1989;2(4):244–245. [PubMed] [Google Scholar]
  7. Bouzas E. A., Parry D. M., Eldridge R., Kaiser-Kupfer M. I. Familial occurrence of combined pigment epithelial and retinal hamartomas associated with neurofibromatosis 2. Retina. 1992;12(2):103–107. doi: 10.1097/00006982-199212020-00005. [DOI] [PubMed] [Google Scholar]
  8. Brownstein S., Little J. M. Ocular neurofibromatosis. Ophthalmology. 1983 Dec;90(12):1595–1599. doi: 10.1016/s0161-6420(83)34371-2. [DOI] [PubMed] [Google Scholar]
  9. Burke J. P., Leitch R. J., Talbot J. F., Parsons M. A. Choroidal neurofibromatosis with congenital iris ectropion and buphthalmos: relationship and significance. J Pediatr Ophthalmol Strabismus. 1991 Sep-Oct;28(5):265–267. doi: 10.3928/0191-3913-19910901-07. [DOI] [PubMed] [Google Scholar]
  10. Carnevale A., Santillán Y. Efecto del sexo del progenitor sobre las manifestaciones clínicas de la neurofibromatosis. Rev Invest Clin. 1991 Oct-Dec;43(4):359–363. [PubMed] [Google Scholar]
  11. Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
  12. Cawthon R. M., Weiss R., Xu G. F., Viskochil D., Culver M., Stevens J., Robertson M., Dunn D., Gesteland R., O'Connell P. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990 Jul 13;62(1):193–201. doi: 10.1016/0092-8674(90)90253-b. [DOI] [PubMed] [Google Scholar]
  13. Charles S. J., Moore A. T., Yates J. R., Ferguson-Smith M. A. Lisch nodules in neurofibromatosis type 2. Case report. Arch Ophthalmol. 1989 Nov;107(11):1571–1572. doi: 10.1001/archopht.1989.01070020649012. [DOI] [PubMed] [Google Scholar]
  14. Cotlier E. Café-au-lait spots of the fundus in neurofibromatosis. Arch Ophthalmol. 1977 Nov;95(11):1990–1992. doi: 10.1001/archopht.1977.04450110084007. [DOI] [PubMed] [Google Scholar]
  15. Cunliffe I. A., Moffat D. A., Hardy D. G., Moore A. T. Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2. Br J Ophthalmol. 1992 May;76(5):310–312. doi: 10.1136/bjo.76.5.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. DeClue J. E., Cohen B. D., Lowy D. R. Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9914–9918. doi: 10.1073/pnas.88.22.9914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Destro M., D'Amico D. J., Gragoudas E. S., Brockhurst R. J., Pinnolis M. K., Albert D. M., Topping T. M., Puliafito C. A. Retinal manifestations of neurofibromatosis. Diagnosis and management. Arch Ophthalmol. 1991 May;109(5):662–666. doi: 10.1001/archopht.1991.01080050076033. [DOI] [PubMed] [Google Scholar]
  18. Dossetor F. M., Landau K., Hoyt W. F. Optic disk glioma in neurofibromatosis type 2. Am J Ophthalmol. 1989 Nov 15;108(5):602–603. doi: 10.1016/0002-9394(89)90445-5. [DOI] [PubMed] [Google Scholar]
  19. Downward J. Signal transduction. Rac and Rho in tune. Nature. 1992 Sep 24;359(6393):273–274. doi: 10.1038/359273a0. [DOI] [PubMed] [Google Scholar]
  20. Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol. 1981;29:57–65. [PubMed] [Google Scholar]
  21. Estivill X., Lázaro C., Casals T., Ravella A. Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1. Hum Genet. 1991 Dec;88(2):185–188. doi: 10.1007/BF00206069. [DOI] [PubMed] [Google Scholar]
  22. Evans D. G., Huson S. M., Donnai D., Neary W., Blair V., Teare D., Newton V., Strachan T., Ramsden R., Harris R. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet. 1992 Dec;29(12):841–846. doi: 10.1136/jmg.29.12.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fountain J. W., Wallace M. R., Bruce M. A., Seizinger B. R., Menon A. G., Gusella J. F., Michels V. V., Schmidt M. A., Dewald G. W., Collins F. S. Physical mapping of a translocation breakpoint in neurofibromatosis. Science. 1989 Jun 2;244(4908):1085–1087. doi: 10.1126/science.2543076. [DOI] [PubMed] [Google Scholar]
  24. Gallie B. L., Dunn J. M., Hamel P. A., Muncaster M., Cohen B. L., Phillips R. A. How do retinoblastoma tumours form? Eye (Lond) 1992;6(Pt 2):226–231. doi: 10.1038/eye.1992.44. [DOI] [PubMed] [Google Scholar]
  25. Gans O. Ein Fall von Neurofibromatosis (Morbus Recklinghausen) dargestellt von J. de Ribera (1588-1656) Hautarzt. 1969 Jan;20(1):332–333. [PubMed] [Google Scholar]
  26. Garretto N. S., Ameriso S., Molina H. A., Arberas C., Salvat J., Monteverde D., Sica R. E. Type 2 neurofibromatosis with Lisch nodules. Neurofibromatosis. 1989;2(5-6):315–321. [PubMed] [Google Scholar]
  27. Gass J. D. An unusual hamartoma of the pigment epithelium and retina simulating choroidal melanoma and retinoblastoma. Trans Am Ophthalmol Soc. 1973;71:171–185. [PMC free article] [PubMed] [Google Scholar]
  28. Glover T. W., Stein C. K., Legius E., Andersen L. B., Brereton A., Johnson S. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer. 1991 Jan;3(1):62–70. doi: 10.1002/gcc.2870030111. [DOI] [PubMed] [Google Scholar]
  29. Good W. V., Erodsky M. C., Edwards M. S., Hoyt W. F. Bilateral retinal hamartomas in neurofibromatosis type 2. Br J Ophthalmol. 1991 Mar;75(3):190–190. doi: 10.1136/bjo.75.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gutmann D. H., Collins F. S. Recent progress toward understanding the molecular biology of von Recklinghausen neurofibromatosis. Ann Neurol. 1992 May;31(5):555–561. doi: 10.1002/ana.410310515. [DOI] [PubMed] [Google Scholar]
  31. Gutmann D. H., Wood D. L., Collins F. S. Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9658–9662. doi: 10.1073/pnas.88.21.9658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hall A. ras and GAP--who's controlling whom? Cell. 1990 Jun 15;61(6):921–923. doi: 10.1016/0092-8674(90)90054-i. [DOI] [PubMed] [Google Scholar]
  33. Hecht F. Recognition of neurofibromatosis before von Recklinghausen. Neurofibromatosis. 1989;2(3):180–184. [PubMed] [Google Scholar]
  34. Hochstrasser H., Boltshauser E., Valavanis A. Brain tumors in children with von Recklinghausen neurofibromatosis. Neurofibromatosis. 1988;1(4):233–239. [PubMed] [Google Scholar]
  35. Hofman K. J., Boehm C. D. Familial neurofibromatosis type 1: clinical experience with DNA testing. J Pediatr. 1992 Mar;120(3):394–398. doi: 10.1016/s0022-3476(05)80903-5. [DOI] [PubMed] [Google Scholar]
  36. Huson S., Jones D., Beck L. Ophthalmic manifestations of neurofibromatosis. Br J Ophthalmol. 1987 Mar;71(3):235–238. doi: 10.1136/bjo.71.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Imes R. K., Hoyt W. F. Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study. Br J Ophthalmol. 1986 Mar;70(3):179–182. doi: 10.1136/bjo.70.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Imes R. K., Hoyt W. F. Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1. Am J Ophthalmol. 1991 Jun 15;111(6):729–734. doi: 10.1016/s0002-9394(14)76780-7. [DOI] [PubMed] [Google Scholar]
  39. Jadayel D., Fain P., Upadhyaya M., Ponder M. A., Huson S. M., Carey J., Fryer A., Mathew C. G., Barker D. F., Ponder B. A. Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature. 1990 Feb 8;343(6258):558–559. doi: 10.1038/343558a0. [DOI] [PubMed] [Google Scholar]
  40. Kaiser-Kupfer M. I., Freidlin V., Datiles M. B., Edwards P. A., Sherman J. L., Parry D., McCain L. M., Eldridge R. The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol. 1989 Apr;107(4):541–544. doi: 10.1001/archopht.1989.01070010555030. [DOI] [PubMed] [Google Scholar]
  41. Kanter W. R., Eldridge R., Fabricant R., Allen J. C., Koerber T. Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology. 1980 Aug;30(8):851–859. doi: 10.1212/wnl.30.8.851. [DOI] [PubMed] [Google Scholar]
  42. Kaye L. D., Rothner A. D., Beauchamp G. R., Meyers S. M., Estes M. L. Ocular findings associated with neurofibromatosis type II. Ophthalmology. 1992 Sep;99(9):1424–1429. doi: 10.1016/s0161-6420(92)31789-0. [DOI] [PubMed] [Google Scholar]
  43. Kayes L. M., Riccardi V. M., Burke W., Bennett R. L., Stephens K. Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet. 1992 Oct;29(10):686–690. doi: 10.1136/jmg.29.10.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Kinzler K. W., Vogelstein B. Cancer. A gene for neurofibromatosis 2. Nature. 1993 Jun 10;363(6429):495–496. doi: 10.1038/363495a0. [DOI] [PubMed] [Google Scholar]
  45. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Kurosawa A., Kurosawa H. Ovoid bodies in choroidal neurofibromatosis. Arch Ophthalmol. 1982 Dec;100(12):1939–1941. doi: 10.1001/archopht.1982.01030040919010. [DOI] [PubMed] [Google Scholar]
  47. Landau K., Dossetor F. M., Hoyt W. F., Muci-Mendoza R. Retinal hamartoma in neurofibromatosis 2. Arch Ophthalmol. 1990 Mar;108(3):328–329. doi: 10.1001/archopht.1990.01070050026011. [DOI] [PubMed] [Google Scholar]
  48. Lee D. K., Abbott M. L. Familial central nervous system neoplasia. Case report of a family with von Recklinghausen's neurofibromatosis. Arch Neurol. 1969 Feb;20(2):154–160. doi: 10.1001/archneur.1969.00480080054006. [DOI] [PubMed] [Google Scholar]
  49. Legius E., Marchuk D. A., Collins F. S., Glover T. W. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet. 1993 Feb;3(2):122–126. doi: 10.1038/ng0293-122. [DOI] [PubMed] [Google Scholar]
  50. Levine A. J., Momand J., Finlay C. A. The p53 tumour suppressor gene. Nature. 1991 Jun 6;351(6326):453–456. doi: 10.1038/351453a0. [DOI] [PubMed] [Google Scholar]
  51. Levine A. J. The p53 tumor-suppressor gene. N Engl J Med. 1992 May 14;326(20):1350–1352. doi: 10.1056/NEJM199205143262008. [DOI] [PubMed] [Google Scholar]
  52. Lewis R. A., Gerson L. P., Axelson K. A., Riccardi V. M., Whitford R. P. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology. 1984 Aug;91(8):929–935. doi: 10.1016/s0161-6420(84)34217-8. [DOI] [PubMed] [Google Scholar]
  53. Li Y., Bollag G., Clark R., Stevens J., Conroy L., Fults D., Ward K., Friedman E., Samowitz W., Robertson M. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell. 1992 Apr 17;69(2):275–281. doi: 10.1016/0092-8674(92)90408-5. [DOI] [PubMed] [Google Scholar]
  54. MARSHALL D. Glioma of the optic nerve as a manifestation of von Recklinghausen's disease. Am J Ophthalmol. 1954 Jan;37(1):15-33; discussion, 33-6. [PubMed] [Google Scholar]
  55. Madigan P., Masello M. J. Report of a neurofibromatosis-like case: Monstrorum Historia, 1642. Neurofibromatosis. 1989;2(1):53–56. [PubMed] [Google Scholar]
  56. Madigan P., Shaw R. V. Neurofibromatosis in 13th century Austria? Neurofibromatosis. 1988;1(5-6):339–341. [PubMed] [Google Scholar]
  57. Marchuk D. A., Saulino A. M., Tavakkol R., Swaroop M., Wallace M. R., Andersen L. B., Mitchell A. L., Gutmann D. H., Boguski M., Collins F. S. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics. 1991 Dec;11(4):931–940. doi: 10.1016/0888-7543(91)90017-9. [DOI] [PubMed] [Google Scholar]
  58. Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990 Nov 16;63(4):843–849. doi: 10.1016/0092-8674(90)90150-d. [DOI] [PubMed] [Google Scholar]
  59. Martuza R. L., Eldridge R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med. 1988 Mar 17;318(11):684–688. doi: 10.1056/NEJM198803173181106. [DOI] [PubMed] [Google Scholar]
  60. Martuza R. L., Philippe I., Fitzpatrick T. B., Zwaan J., Seki Y., Lederman J. Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study. J Invest Dermatol. 1985 Oct;85(4):347–350. doi: 10.1111/1523-1747.ep12276952. [DOI] [PubMed] [Google Scholar]
  61. Mayfrank L., Wullich B., Wolff G., Finke J., Gouzoulis E., Gilsbach J. M. Neurofibromatosis 2: a clinically and genetically heterogeneous disease? Report on 10 sporadic cases. Clin Genet. 1990 Nov;38(5):362–370. doi: 10.1111/j.1399-0004.1990.tb03596.x. [DOI] [PubMed] [Google Scholar]
  62. Menon A. G., Anderson K. M., Riccardi V. M., Chung R. Y., Whaley J. M., Yandell D. W., Farmer G. E., Freiman R. N., Lee J. K., Li F. P. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5435–5439. doi: 10.1073/pnas.87.14.5435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Menon A. G., Gusella J. F., Seizinger B. R. Progress towards the isolation and characterization of the genes causing neurofibromatosis. Cancer Surv. 1990;9(4):689–702. [PubMed] [Google Scholar]
  64. Menon A. G., Ledbetter D. H., Rich D. C., Seizinger B. R., Rouleau G. A., Michels V. F., Schmidt M. A., Dewald G., DallaTorre C. M., Haines J. L. Characterization of a translocation within the von Recklinghausen neurofibromatosis region of chromosome 17. Genomics. 1989 Aug;5(2):245–249. doi: 10.1016/0888-7543(89)90053-0. [DOI] [PubMed] [Google Scholar]
  65. Miller M., Hall J. G. Possible maternal effect on severity of neurofibromatosis. Lancet. 1978 Nov 18;2(8099):1071–1073. doi: 10.1016/s0140-6736(78)91804-4. [DOI] [PubMed] [Google Scholar]
  66. Mulvihill J. J., Parry D. M., Sherman J. L., Pikus A., Kaiser-Kupfer M. I., Eldridge R. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med. 1990 Jul 1;113(1):39–52. doi: 10.7326/0003-4819-113-1-39. [DOI] [PubMed] [Google Scholar]
  67. Musarella M. A. Gene mapping of ocular diseases. Surv Ophthalmol. 1992 Jan-Feb;36(4):285–312. doi: 10.1016/0039-6257(92)90096-c. [DOI] [PubMed] [Google Scholar]
  68. Narod S. A., Parry D. M., Parboosingh J., Lenoir G. M., Ruttledge M., Fischer G., Eldridge R., Martuza R. L., Frontali M., Haines J. Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am J Hum Genet. 1992 Sep;51(3):486–496. [PMC free article] [PubMed] [Google Scholar]
  69. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989 Dec 7;342(6250):705–708. doi: 10.1038/342705a0. [DOI] [PubMed] [Google Scholar]
  70. Nordmann J., Brini A. Von Recklinghausen's disease and melanoma of the uvea. Br J Ophthalmol. 1970 Oct;54(10):641–648. doi: 10.1136/bjo.54.10.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. O'Connell P., Leach R., Cawthon R. M., Culver M., Stevens J., Viskochil D., Fournier R. E., Rich D. C., Ledbetter D. H., White R. Two NF1 translocations map within a 600-kilobase segment of 17q11.2. Science. 1989 Jun 2;244(4908):1087–1088. doi: 10.1126/science.2543077. [DOI] [PubMed] [Google Scholar]
  72. Packer R. J., Bilaniuk L. T., Cohen B. H., Braffman B. H., Obringer A. C., Zimmerman R. A., Siegel K. R., Sutton L. N., Savino P. J., Zackai E. H. Intracranial visual pathway gliomas in children with neurofibromatosis. Neurofibromatosis. 1988;1(4):212–222. [PubMed] [Google Scholar]
  73. Palmer M. L., Carney M. D., Combs J. L. Combined hamartomas of the retinal pigment epithelium and retina. Retina. 1990;10(1):33–36. [PubMed] [Google Scholar]
  74. Pearson-Webb M. A., Kaiser-Kupfer M. I., Eldridge R. Eye findings in bilateral acoustic (central) neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules. N Engl J Med. 1986 Dec 11;315(24):1553–1554. doi: 10.1056/NEJM198612113152419. [DOI] [PubMed] [Google Scholar]
  75. Pulst S. M. Prenatal diagnosis of the neurofibromatoses. Clin Perinatol. 1990 Dec;17(4):829–844. [PubMed] [Google Scholar]
  76. Ragge N. K., Falk R. E., Cohen W. E., Murphree A. L. Images of Lisch nodules across the spectrum. Eye (Lond) 1993;7(Pt 1):95–101. doi: 10.1038/eye.1993.20. [DOI] [PubMed] [Google Scholar]
  77. Riccardi V. M., Lewis R. A. Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet. 1988 Feb;42(2):284–289. [PMC free article] [PubMed] [Google Scholar]
  78. Riccardi V. M., Powell P. P. Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis. Neurofibromatosis. 1989;2(3):152–165. [PubMed] [Google Scholar]
  79. Riccardi V. M. Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr. 1992 Feb;22(2):66–107. doi: 10.1016/0045-9380(92)90053-2. [DOI] [PubMed] [Google Scholar]
  80. Riccardi V. M. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981 Dec 31;305(27):1617–1627. doi: 10.1056/NEJM198112313052704. [DOI] [PubMed] [Google Scholar]
  81. Riccardi V. M., Wald J. S. Discounting an adverse maternal effect on severity of neurofibromatosis. Pediatrics. 1987 Mar;79(3):386–393. [PubMed] [Google Scholar]
  82. Rouleau G. A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993 Jun 10;363(6429):515–521. doi: 10.1038/363515a0. [DOI] [PubMed] [Google Scholar]
  83. Rouleau G. A., Wertelecki W., Haines J. L., Hobbs W. J., Trofatter J. A., Seizinger B. R., Martuza R. L., Superneau D. W., Conneally P. M., Gusella J. F. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature. 1987 Sep 17;329(6136):246–248. doi: 10.1038/329246a0. [DOI] [PubMed] [Google Scholar]
  84. Rush J. A., Younge B. R., Campbell R. J., MacCarty C. S. Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology. 1982 Nov;89(11):1213–1219. [PubMed] [Google Scholar]
  85. Seidel H. M., Pompliano D. L., Knowles J. R. Exons as microgenes? Science. 1992 Sep 11;257(5076):1489–1490. doi: 10.1126/science.1523407. [DOI] [PubMed] [Google Scholar]
  86. Seiff S. R., Brodsky M. C., MacDonald G., Berg B. O., Howes E. L., Jr, Hoyt W. F. Orbital optic glioma in neurofibromatosis. Magnetic resonance diagnosis of perineural arachnoidal gliomatosis. Arch Ophthalmol. 1987 Dec;105(12):1689–1692. doi: 10.1001/archopht.1987.01060120087032. [DOI] [PubMed] [Google Scholar]
  87. Seizinger B. R., Martuza R. L., Gusella J. F. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature. 1986 Aug 14;322(6080):644–647. doi: 10.1038/322644a0. [DOI] [PubMed] [Google Scholar]
  88. Seizinger B. R. NF1: a prevalent cause of tumorigenesis in human cancers? Nat Genet. 1993 Feb;3(2):97–99. doi: 10.1038/ng0293-97. [DOI] [PubMed] [Google Scholar]
  89. Seizinger B. R., Rouleau G., Ozelius L. J., Lane A. H., St George-Hyslop P., Huson S., Gusella J. F., Martuza R. L. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science. 1987 Apr 17;236(4799):317–319. doi: 10.1126/science.3105060. [DOI] [PubMed] [Google Scholar]
  90. Seizinger B. R., de la Monte S., Atkins L., Gusella J. F., Martuza R. L. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5419–5423. doi: 10.1073/pnas.84.15.5419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Shannon K. M., Watterson J., Johnson P., O'Connell P., Lange B., Shah N., Steinherz P., Kan Y. W., Priest J. R. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis. Blood. 1992 Mar 1;79(5):1311–1318. [PubMed] [Google Scholar]
  92. Sidransky D., Mikkelsen T., Schwechheimer K., Rosenblum M. L., Cavanee W., Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature. 1992 Feb 27;355(6363):846–847. doi: 10.1038/355846a0. [DOI] [PubMed] [Google Scholar]
  93. Sivalingam A., Augsburger J., Perilongo G., Zimmerman R., Barabas G. Combined hamartoma of the retina and retinal pigment epithelium in a patient with neurofibromatosis type 2. J Pediatr Ophthalmol Strabismus. 1991 Nov-Dec;28(6):320–322. doi: 10.3928/0191-3913-19911101-08. [DOI] [PubMed] [Google Scholar]
  94. Skuse G. R., Kosciolek B. A., Rowley P. T. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer. 1989 Sep;1(1):36–41. doi: 10.1002/gcc.2870010107. [DOI] [PubMed] [Google Scholar]
  95. Skuse G. R., Kosciolek B. A., Rowley P. T. The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet. 1991 Sep;49(3):600–607. [PMC free article] [PubMed] [Google Scholar]
  96. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  97. Srivastava S., Zou Z. Q., Pirollo K., Blattner W., Chang E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990 Dec 20;348(6303):747–749. doi: 10.1038/348747a0. [DOI] [PubMed] [Google Scholar]
  98. Stark M., Assum G., Krone W. A small deletion and an adjacent base exchange in a potential stem-loop region of the neurofibromatosis 1 gene. Hum Genet. 1991 Oct;87(6):685–687. doi: 10.1007/BF00201726. [DOI] [PubMed] [Google Scholar]
  99. Stern J., Jakobiec F. A., Housepian E. M. The architecture of optic nerve gliomas with and without neurofibromatosis. Arch Ophthalmol. 1980 Mar;98(3):505–511. doi: 10.1001/archopht.1980.01020030501014. [DOI] [PubMed] [Google Scholar]
  100. Sørensen S. A., Mulvihill J. J., Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986 Apr 17;314(16):1010–1015. doi: 10.1056/NEJM198604173141603. [DOI] [PubMed] [Google Scholar]
  101. T'Ang A., Varley J. M., Chakraborty S., Murphree A. L., Fung Y. K. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science. 1988 Oct 14;242(4876):263–266. doi: 10.1126/science.3175651. [DOI] [PubMed] [Google Scholar]
  102. Toguchida J., Yamaguchi T., Dayton S. H., Beauchamp R. L., Herrera G. E., Ishizaki K., Yamamuro T., Meyers P. A., Little J. B., Sasaki M. S. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med. 1992 May 14;326(20):1301–1308. doi: 10.1056/NEJM199205143262001. [DOI] [PubMed] [Google Scholar]
  103. Toonstra J., Dandrieu M. R., Ippel P. F., Delleman J. W., Rupert P. H., Jr, Huitema H. B. Are Lisch nodules an ocular marker of the neurofibromatosis gene in otherwise unaffected family members? Dermatologica. 1987;174(5):232–235. doi: 10.1159/000249186. [DOI] [PubMed] [Google Scholar]
  104. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
  105. Upadhyaya M., Cheryson A., Broadhead W., Fryer A., Shaw D. J., Huson S., Wallace M. R., Andersen L. B., Marchuk D. A., Viskochil D. A 90 kb DNA deletion associated with neurofibromatosis type 1. J Med Genet. 1990 Dec;27(12):738–741. doi: 10.1136/jmg.27.12.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Venter D. J., Bevan K. L., Ludwig R. L., Riley T. E., Jat P. S., Thomas D. G., Noble M. D. Retinoblastoma gene deletions in human glioblastomas. Oncogene. 1991 Mar;6(3):445–448. [PubMed] [Google Scholar]
  107. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  108. Vogelstein B. Cancer. A deadly inheritance. Nature. 1990 Dec 20;348(6303):681–682. doi: 10.1038/348681a0. [DOI] [PubMed] [Google Scholar]
  109. WOLTER J. R., GONZALES-SIRIT R., MANKIN W. J. Neuro-fibromatosis of the choroid. Am J Ophthalmol. 1962 Aug;54:217–225. [PubMed] [Google Scholar]
  110. Wallace M. R., Andersen L. B., Saulino A. M., Gregory P. E., Glover T. W., Collins F. S. A de novo Alu insertion results in neurofibromatosis type 1. Nature. 1991 Oct 31;353(6347):864–866. doi: 10.1038/353864a0. [DOI] [PubMed] [Google Scholar]
  111. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]
  112. Wertelecki W., Rouleau G. A., Superneau D. W., Forehand L. W., Williams J. P., Haines J. L., Gusella J. F. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med. 1988 Aug 4;319(5):278–283. doi: 10.1056/NEJM198808043190505. [DOI] [PubMed] [Google Scholar]
  113. Wolff R. K., Frazer K. A., Jackler R. K., Lanser M. J., Pitts L. H., Cox D. R. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet. 1992 Sep;51(3):478–485. [PMC free article] [PubMed] [Google Scholar]
  114. Wong J. Y., Uhl V., Wara W. M., Sheline G. E. Optic gliomas. A reanalysis of the University of California, San Francisco experience. Cancer. 1987 Oct 15;60(8):1847–1855. doi: 10.1002/1097-0142(19871015)60:8<1847::aid-cncr2820600829>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  115. Xu G. F., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990 Aug 10;62(3):599–608. doi: 10.1016/0092-8674(90)90024-9. [DOI] [PubMed] [Google Scholar]
  116. Young D. F., Eldridge R., Nager G. T., Deland F. H., McNew J. Hereditary bilateral acoustic neuroma (central neurofibromatosis). Birth Defects Orig Artic Ser. 1971 Mar;07(4):73–86. [PubMed] [Google Scholar]
  117. Zanca A., Zanca A. Antique illustrations of neurofibromatosis. Int J Dermatol. 1980 Jan-Feb;19(1):55–58. doi: 10.1111/j.1365-4362.1980.tb01998.x. [DOI] [PubMed] [Google Scholar]
  118. el-Azouzi M., Chung R. Y., Farmer G. E., Martuza R. L., Black P. M., Rouleau G. A., Hettlich C., Hedley-Whyte E. T., Zervas N. T., Panagopoulos K. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7186–7190. doi: 10.1073/pnas.86.18.7186. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES